免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA PMA

自動胰島素劑量設備系統,單一激素控制

PMA 核准號:P160017 · 2026-08-05

決定日期2026-08-05
PMA 編號P160017
產品代碼OZP
器械分類3 類
醫療專科U
諮詢委員會CH

器材摘要

Automated insulin dosing device system, single hormonal control is the device name listed in this FDA 510(k) record. The listed applicant is Medtronic Minimed, Inc.. It received FDA 510(k) clearance on 2026-08-05. The device is classified under product code OZP. It was reviewed by the CH advisory panel.

常見問題

What is the Automated insulin dosing device system, single hormonal control?

Automated insulin dosing device system, single hormonal control is a medical device that received FDA 510(k) clearance on 2026-08-05. The listed applicant is Medtronic Minimed, Inc..

When did Automated insulin dosing device system, single hormonal control receive FDA 510(k) clearance?

The clearance date for Automated insulin dosing device system, single hormonal control can be found in the official FDA records.

誰是自動輸注設備系統、單一激素控制所列申請人?

The FDA 510(k) record lists Medtronic Minimed, Inc. as the applicant. This does not by itself establish the device manufacturer.

FDA產品代碼是什麼?自動胰島素劑量設備系統,單一激素控制?

FDA產品代碼對於自動胰島素劑量設備系統,單一激素控制為OZP。

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑